Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Exelixis, Inc.(EXEL) | 1,566,140 | 1,677,393 | +111,253 | $37.2K | $37.7K | 17.31% | +$526 |
| United Therapeutics Corporation(UTHR) | 156,714 | 118,208 | -38,506 | $36.0K | $37.7K | 17.29% | +$1.7K |
| Biogen Inc.(BIIB) | 134,068 | 123,785 | -10,283 | $28.9K | $28.7K | 13.18% | -$213 |
| Taro Pharmaceutical Indus | 647,868 | 650,089 | +2,221 | $27.4K | $28.0K | 12.83% | +$523 |
| Cardinal Health, Inc.(CAH) | 235,656 | 217,656 | -18,000 | $26.4K | $21.4K | 9.83% | -$5.0K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 1,124,586 | 1,251,338 | +126,752 | $19.6K | $16.2K | 7.45% | -$3.4K |
| Jazz Pharmaceuticals plc(JAZZ) | 101,151 | 109,076 | +7,925 | $12.2K | $11.6K | 5.35% | -$539 |
| BioNTech SE(BNTX) | 120,000 | 132,293 | +12,293 | $11.1K | $10.6K | 4.88% | -$439 |
| Regeneron Pharmaceuticals, Inc.(REGN) | 12,494 | 7,853 | -4,641 | $12.0K | $8.3K | 3.79% | -$3.8K |
| Sanofi(SNY) | 150,959 | 153,832 | +2,873 | $7.3K | $7.5K | 3.43% | +$127 |
| Alkermes plc(ALKS) | 257,554 | 257,554 | 0 | $7.0K | $6.2K | 2.85% | -$765 |
| Vanda Pharmaceuticals Inc.(VNDA) | 0 | 662,166 | +662,166 | $0 | $3.7K | 1.72% | +$3.7K |
| Mural Oncology Plc | 88,001 | 75,057 | -12,944 | $430 | $236 | 0.11% | -$194 |